RAD52
MOLECULAR TARGETRAD52 DNA repair protein
RAD52 (RAD52 DNA repair protein) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting RAD52
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | egcg | 2.40 | 10 |
| 2 | Perphenazine | 1.39 | 3 |
| 3 | Thioridazine | 1.39 | 3 |
| 4 | Methylene Blue | 1.10 | 2 |
| 5 | Chlorhexidine | 1.10 | 2 |
| 6 | Imatinib Mesylate | 1.10 | 2 |
| 7 | propionylpromazine hydrochloride | 1.10 | 2 |
| 8 | Aurintricarboxylic Acid | 0.69 | 1 |
| 9 | Catechin | 0.69 | 1 |
| 10 | Procaine | 0.69 | 1 |
| 11 | Sphingosine | 0.69 | 1 |
About RAD52 as a Drug Target
RAD52 (RAD52 DNA repair protein) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented RAD52 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
RAD52 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.